Mucormycosis in CAPA, a Possible Fungal Super-Infection

The occurrence of pulmonary fungal superinfection due to Aspergillus spp. in patients with COVID-19 is a well-described complication associated with significant morbidity and mortality. This can be related to a directed effect of the virus and to the immunosuppressive role of the therapies administe...

Descripción completa

Detalles Bibliográficos
Autores principales: Saltini, Paola, Palomba, Emanuele, Castelli, Valeria, Fava, Marco, Alagna, Laura, Biscarini, Simona, Mantero, Marco, Blasi, Francesco, Grancini, Anna, Bandera, Alessandra, Gori, Andrea, Muscatello, Antonio, Lombardi, Andrea
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8472188/
https://www.ncbi.nlm.nih.gov/pubmed/34575746
http://dx.doi.org/10.3390/jof7090708
Descripción
Sumario:The occurrence of pulmonary fungal superinfection due to Aspergillus spp. in patients with COVID-19 is a well-described complication associated with significant morbidity and mortality. This can be related to a directed effect of the virus and to the immunosuppressive role of the therapies administered for the disease. Here, we describe the first case of pulmonary infection due to Mucorales occurring in a patient with a concomitant diagnosis of COVID-19-associated pulmonary aspergillosis.

Ejemplares similares